CompletedPhase 2NCT06334419

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Craig Erickson
Principal Investigator
Cragi A Erickson, MD
Children's Hospital Medical Center, Cincinnati
Intervention
Gaboxadol(drug)
Enrollment
10 enrolled
Eligibility
18-40 years · MALE
Timeline
20242025

Study locations (1)

Collaborators

Healx Limited

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06334419 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials